Digital Memory Notebook for Cognitive Impairment
(DMN Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Digital Memory Notebook treatment for cognitive impairment?
Research shows that the Digital Memory Notebook (DMN) app is user-friendly and helps people with cognitive impairment complete tasks faster and with high satisfaction. In case studies, participants reported fewer memory lapses and improved daily functioning after using the DMN, indicating it may help maintain independence and quality of life.12345
How is the Digital Memory Notebook treatment unique for cognitive impairment?
The Digital Memory Notebook (DMN) is unique because it is a digital application designed to serve as an 'all-in-one' memory aid and organizational tool, improving everyday functioning for individuals with cognitive impairment. Unlike traditional paper-and-pencil memory aids, the DMN offers features like a today page, to-do list, calendar, notes, journaling, and alarms, all of which are designed to support memory and enhance quality of life.12567
What is the purpose of this trial?
Compensatory aids (e.g., alarms, calendars) play an important supporting role when completing everyday tasks (e.g., appointments, medication management), and there is a growing body of scientific work suggesting that compensatory training improves daily functioning. However, traditional paper-based calendars and to-do-lists have limitations related to accumulation of information, difficulty retrieving information, and remembering to complete activities. Such limitations may be overcome using a digital format through organized digital files, search functions, and alarms. This pilot project proposes to train older adults at risk for cognitive decline to use the Digital Memory Notebook (DMN), a tablet-based application (app), to support everyday functioning. The primary goal is to obtain preliminary evidence that a 6-week, individual and group-based DMN training intervention results in demonstrable changes in target behaviors (e.g., goal-directed DMN use to support everyday activities) among older adults with mild cognitive impairment (MCI) and subjective cognitive complaints (SCC). Participants will complete a curriculum involving 2-hour weekly sessions for 6-weeks. Each week will cover a specific function of the DMN and will include standardized goal-setting and weekly homework targets. Following the 6-week intervention, participants will continue to use the DMN app for 4-weeks to evaluate stability. Participants will complete a questionnaire packet 1 week prior to the 6-week intervention, 1 week after the 6-week intervention, and 5 weeks following the 6-week intervention. MCI and SCC participants will complete separate 6-week individual or group interventions spaced two months apart at UCD.
Research Team
Sarah Farias, PhD
Principal Investigator
University of California, Davis
Eligibility Criteria
This trial is for English-speaking adults aged 60 or older with mild cognitive impairment (MCI) or subjective cognitive complaints (SCC). They must have someone to help with surveys. Pregnant women, those unable to consent, and prisoners are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
DMN Training Intervention
Participants attend 2-hour weekly sessions for 6 weeks to learn how to use the Digital Memory Notebook (DMN) to support everyday functioning
Stability Evaluation
Participants continue to use the DMN app for 4 weeks to evaluate stability
Follow-up
Participants are monitored for changes in target behaviors and complete questionnaires at specified intervals
Treatment Details
Interventions
- Digital Memory Notebook (DMN) Application
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor